Competitive and Noncompetitive Inhibition of the DNA-dependent Protein Kinase
Overview
Authors
Affiliations
The DNA-dependent protein kinase (DNA-PK) is a serine/threonine protein kinase that is involved in mammalian DNA double-strand break repair. The catalytic subunit of DNA-PK (DNA-PKcs) shares sequence homology in its kinase domain with phosphatidylinositol (PI) 3-kinase. Here, we provide a detailed kinetic analysis of DNA-PK inhibition by the PI 3-kinase inhibitor wortmannin and demonstrate this inhibition to be of a noncompetitive nature, with a Ki of 120 nM. Another inhibitor of PI 3-kinase. LY294002, its parent compound, quercetin, and other derivatives have also been studied. These chemicals are competitive inhibitors of DNA-PK, with LY294002 having a Ki of 6.0 microM. Using an antibody to wortmannin, we found that this compound binds covalently to the kinase domain of DNA-PKcs both in vitro and in vivo. Binding of wortmannin to the active site of DNA-PKcs is inhibited by ATP but not by a peptide substrate. Furthermore, wortmannin is able to bind to DNA-PKcs independently of Ku, and it is not stimulated by the presence of DNA. This suggests that the ATP binding site of DNA-PKcs is open constitutively and that DNA activation of the kinase is mediated via another mechanism.
Development and Evolution of DNA-Dependent Protein Kinase Inhibitors toward Cancer Therapy.
Matsumoto Y Int J Mol Sci. 2022; 23(8).
PMID: 35457081 PMC: 9032228. DOI: 10.3390/ijms23084264.
Emerging Therapeutic Targets Against : Update on DNA Repair Response Inhibitors and Genotoxic Drugs.
Angel S, Vanagas L, Ruiz D, Cristaldi C, Saldarriaga Cartagena A, Sullivan Jr W Front Cell Infect Microbiol. 2020; 10:289.
PMID: 32656097 PMC: 7325978. DOI: 10.3389/fcimb.2020.00289.
Anne Esguerra Z, Watanabe G, Okitsu C, Hsieh C, Lieber M Mol Immunol. 2020; 120:93-100.
PMID: 32113132 PMC: 7184946. DOI: 10.1016/j.molimm.2020.01.018.
Muller A, Gillissen B, Richter A, Richter A, Chumduri C, Daniel P Cell Death Dis. 2018; 9(3):384.
PMID: 29515122 PMC: 5841308. DOI: 10.1038/s41419-018-0413-4.
The Role of the Core Non-Homologous End Joining Factors in Carcinogenesis and Cancer.
Sishc B, Davis A Cancers (Basel). 2017; 9(7).
PMID: 28684677 PMC: 5532617. DOI: 10.3390/cancers9070081.